Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTHER trial: Low-dose intrathecal morphine following planned caesarean section
2024-518678-16-00Phase 4Authorised
- Sponsor
- Region Zealand
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute postoperative pain comparing Low-dose intrathecal morphine with Placebo intrathecal sodium chloride (2 arms). Primary endpoints: Level of pain when mobilising from supine to sitting position within 24 hours and Maternal and neonatal safety composite endpoint. Planned start May 2025; status: authorised.
02
Drugs
morphine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on 2024-518678-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518678-16-00.